Touchlight, a biotechnology company pioneering enzymatic DNA production to enable genetic medicines, today announced a ground-breaking new milestone for its enzymatic doggybone DNA (dbDNA™), following the FDA acceptance of the Drug Master File (DMF) for GMP grade dbDNA. This achievement marks the first time a DMF has been accepted for an enzymatically produced DNA platform. Source: BIA News 24/1/2023